Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-01-01 @ 12:13 PM
Study NCT ID:
NCT03977467
Status:
COMPLETED
Last Update Posted:
2025-08-27
First Post:
2019-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor
Sponsor:
SCRI Development Innovations, LLC